TORONTO, Oct. 13, 2017 (GLOBE NEWSWIRE) — The Canadian Bioceutical Corporation (the “Company” or “BCC”) (CSE:BCC) (OTC:CBICF) today announced that the Company will hold its annual and special meeting of shareholders (“Annual Meeting”) of BCC on Monday, October 30, 2017 to consider the following matters:
To elect the directors of the Company for the ensuing year To appoint Deloitte LLP as the auditors of the Company for the ensuing year and authorizing the directors to fix their remuneration To amend the articles of BCC to change the name of the Company to “MPX Bioceutical Corporation”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.